Global Drug Repurposing Market Growth (Status and Outlook) 2022-2028
- LP 4786365
- 85 Pages
- January 2022
- Pharmaceuticals
The United States Drug Repurposing market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Drug Repurposing market, reaching US$ million by the year 2028. As for the Europe Drug Repurposing landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Drug Repurposing players cover Astellas Pharma, Biovista, Novartis, and AbbVie, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug Repurposing market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Oncology
CNS Diseases
Neurodegenerative Diseases
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospitals
Ambulatory Surgical Centers
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Astellas Pharma
Biovista
Novartis
AbbVie
Pfizer
Allergan
NuMedii
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drug Repurposing Market Size 2017-2028
2.1.2 Drug Repurposing Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Drug Repurposing Segment by Type
2.2.1 Oncology
2.2.2 CNS Diseases
2.2.3 Neurodegenerative Diseases
2.2.4 Others
2.3 Drug Repurposing Market Size by Type
2.3.1 Drug Repurposing Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Drug Repurposing Market Size Market Share by Type (2017-2022)
2.4 Drug Repurposing Segment by Application
2.4.1 Hospitals
2.4.2 Ambulatory Surgical Centers
2.4.3 Others
2.5 Drug Repurposing Market Size by Application
2.5.1 Drug Repurposing Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Drug Repurposing Market Size Market Share by Application (2017-2022)
3 Drug Repurposing Market Size by Player
3.1 Drug Repurposing Market Size Market Share by Players
3.1.1 Global Drug Repurposing Revenue by Players (2020-2022)
3.1.2 Global Drug Repurposing Revenue Market Share by Players (2020-2022)
3.2 Global Drug Repurposing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Drug Repurposing by Regions
4.1 Drug Repurposing Market Size by Regions (2017-2022)
4.2 Americas Drug Repurposing Market Size Growth (2017-2022)
4.3 APAC Drug Repurposing Market Size Growth (2017-2022)
4.4 Europe Drug Repurposing Market Size Growth (2017-2022)
4.5 Middle East & Africa Drug Repurposing Market Size Growth (2017-2022)
5 Americas
5.1 Americas Drug Repurposing Market Size by Country (2017-2022)
5.2 Americas Drug Repurposing Market Size by Type (2017-2022)
5.3 Americas Drug Repurposing Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug Repurposing Market Size by Region (2017-2022)
6.2 APAC Drug Repurposing Market Size by Type (2017-2022)
6.3 APAC Drug Repurposing Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Drug Repurposing by Country (2017-2022)
7.2 Europe Drug Repurposing Market Size by Type (2017-2022)
7.3 Europe Drug Repurposing Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Drug Repurposing by Region (2017-2022)
8.2 Middle East & Africa Drug Repurposing Market Size by Type (2017-2022)
8.3 Middle East & Africa Drug Repurposing Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Drug Repurposing Market Forecast
10.1 Global Drug Repurposing Forecast by Regions (2023-2028)
10.1.1 Global Drug Repurposing Forecast by Regions (2023-2028)
10.1.2 Americas Drug Repurposing Forecast
10.1.3 APAC Drug Repurposing Forecast
10.1.4 Europe Drug Repurposing Forecast
10.1.5 Middle East & Africa Drug Repurposing Forecast
10.2 Americas Drug Repurposing Forecast by Country (2023-2028)
10.2.1 United States Drug Repurposing Market Forecast
10.2.2 Canada Drug Repurposing Market Forecast
10.2.3 Mexico Drug Repurposing Market Forecast
10.2.4 Brazil Drug Repurposing Market Forecast
10.3 APAC Drug Repurposing Forecast by Region (2023-2028)
10.3.1 China Drug Repurposing Market Forecast
10.3.2 Japan Drug Repurposing Market Forecast
10.3.3 Korea Drug Repurposing Market Forecast
10.3.4 Southeast Asia Drug Repurposing Market Forecast
10.3.5 India Drug Repurposing Market Forecast
10.3.6 Australia Drug Repurposing Market Forecast
10.4 Europe Drug Repurposing Forecast by Country (2023-2028)
10.4.1 Germany Drug Repurposing Market Forecast
10.4.2 France Drug Repurposing Market Forecast
10.4.3 UK Drug Repurposing Market Forecast
10.4.4 Italy Drug Repurposing Market Forecast
10.4.5 Russia Drug Repurposing Market Forecast
10.5 Middle East & Africa Drug Repurposing Forecast by Region (2023-2028)
10.5.1 Egypt Drug Repurposing Market Forecast
10.5.2 South Africa Drug Repurposing Market Forecast
10.5.3 Israel Drug Repurposing Market Forecast
10.5.4 Turkey Drug Repurposing Market Forecast
10.5.5 GCC Countries Drug Repurposing Market Forecast
10.6 Global Drug Repurposing Forecast by Type (2023-2028)
10.7 Global Drug Repurposing Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Astellas Pharma
11.1.1 Astellas Pharma Company Information
11.1.2 Astellas Pharma Drug Repurposing Product Offered
11.1.3 Astellas Pharma Drug Repurposing Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Astellas Pharma Main Business Overview
11.1.5 Astellas Pharma Latest Developments
11.2 Biovista
11.2.1 Biovista Company Information
11.2.2 Biovista Drug Repurposing Product Offered
11.2.3 Biovista Drug Repurposing Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Biovista Main Business Overview
11.2.5 Biovista Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Drug Repurposing Product Offered
11.3.3 Novartis Drug Repurposing Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 AbbVie
11.4.1 AbbVie Company Information
11.4.2 AbbVie Drug Repurposing Product Offered
11.4.3 AbbVie Drug Repurposing Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 AbbVie Main Business Overview
11.4.5 AbbVie Latest Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Drug Repurposing Product Offered
11.5.3 Pfizer Drug Repurposing Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Pfizer Main Business Overview
11.5.5 Pfizer Latest Developments
11.6 Allergan
11.6.1 Allergan Company Information
11.6.2 Allergan Drug Repurposing Product Offered
11.6.3 Allergan Drug Repurposing Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Allergan Main Business Overview
11.6.5 Allergan Latest Developments
11.7 NuMedii
11.7.1 NuMedii Company Information
11.7.2 NuMedii Drug Repurposing Product Offered
11.7.3 NuMedii Drug Repurposing Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 NuMedii Main Business Overview
11.7.5 NuMedii Latest Developments
12 Research Findings and Conclusion
Table 1. Drug Repurposing Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Oncology
Table 3. Major Players of CNS Diseases
Table 4. Major Players of Neurodegenerative Diseases
Table 5. Major Players of Others
Table 6. Drug Repurposing Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Drug Repurposing Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Drug Repurposing Market Size Market Share by Type (2017-2022)
Table 9. Drug Repurposing Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Drug Repurposing Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Drug Repurposing Market Size Market Share by Application (2017-2022)
Table 12. Global Drug Repurposing Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Drug Repurposing Revenue Market Share by Player (2020-2022)
Table 14. Drug Repurposing Key Players Head office and Products Offered
Table 15. Drug Repurposing Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Drug Repurposing Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Drug Repurposing Market Size Market Share by Regions (2017-2022)
Table 20. Americas Drug Repurposing Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Drug Repurposing Market Size Market Share by Country (2017-2022)
Table 22. Americas Drug Repurposing Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Drug Repurposing Market Size Market Share by Type (2017-2022)
Table 24. Americas Drug Repurposing Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Drug Repurposing Market Size Market Share by Application (2017-2022)
Table 26. APAC Drug Repurposing Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Drug Repurposing Market Size Market Share by Region (2017-2022)
Table 28. APAC Drug Repurposing Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Drug Repurposing Market Size Market Share by Type (2017-2022)
Table 30. APAC Drug Repurposing Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Drug Repurposing Market Size Market Share by Application (2017-2022)
Table 32. Europe Drug Repurposing Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Drug Repurposing Market Size Market Share by Country (2017-2022)
Table 34. Europe Drug Repurposing Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Drug Repurposing Market Size Market Share by Type (2017-2022)
Table 36. Europe Drug Repurposing Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Drug Repurposing Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Drug Repurposing Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Drug Repurposing Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Drug Repurposing Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Drug Repurposing Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Drug Repurposing Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Drug Repurposing Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Drug Repurposing
Table 45. Key Market Challenges & Risks of Drug Repurposing
Table 46. Key Industry Trends of Drug Repurposing
Table 47. Global Drug Repurposing Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Drug Repurposing Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Drug Repurposing Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Drug Repurposing Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Drug Repurposing Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Drug Repurposing Market Size Market Share Forecast by Application (2023-2028)
Table 53. Astellas Pharma Details, Company Type, Drug Repurposing Area Served and Its Competitors
Table 54. Astellas Pharma Drug Repurposing Product Offered
Table 55. Astellas Pharma Drug Repurposing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. Astellas Pharma Main Business
Table 57. Astellas Pharma Latest Developments
Table 58. Biovista Details, Company Type, Drug Repurposing Area Served and Its Competitors
Table 59. Biovista Drug Repurposing Product Offered
Table 60. Biovista Main Business
Table 61. Biovista Drug Repurposing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. Biovista Latest Developments
Table 63. Novartis Details, Company Type, Drug Repurposing Area Served and Its Competitors
Table 64. Novartis Drug Repurposing Product Offered
Table 65. Novartis Main Business
Table 66. Novartis Drug Repurposing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. Novartis Latest Developments
Table 68. AbbVie Details, Company Type, Drug Repurposing Area Served and Its Competitors
Table 69. AbbVie Drug Repurposing Product Offered
Table 70. AbbVie Main Business
Table 71. AbbVie Drug Repurposing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. AbbVie Latest Developments
Table 73. Pfizer Details, Company Type, Drug Repurposing Area Served and Its Competitors
Table 74. Pfizer Drug Repurposing Product Offered
Table 75. Pfizer Main Business
Table 76. Pfizer Drug Repurposing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. Pfizer Latest Developments
Table 78. Allergan Details, Company Type, Drug Repurposing Area Served and Its Competitors
Table 79. Allergan Drug Repurposing Product Offered
Table 80. Allergan Main Business
Table 81. Allergan Drug Repurposing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 82. Allergan Latest Developments
Table 83. NuMedii Details, Company Type, Drug Repurposing Area Served and Its Competitors
Table 84. NuMedii Drug Repurposing Product Offered
Table 85. NuMedii Main Business
Table 86. NuMedii Drug Repurposing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 87. NuMedii Latest Developments
List of Figures
Figure 1. Drug Repurposing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Drug Repurposing Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Drug Repurposing Market Size Market Share by Type in 2021
Figure 7. Drug Repurposing in Hospitals
Figure 8. Global Drug Repurposing Market: Hospitals (2017-2022) & ($ Millions)
Figure 9. Drug Repurposing in Ambulatory Surgical Centers
Figure 10. Global Drug Repurposing Market: Ambulatory Surgical Centers (2017-2022) & ($ Millions)
Figure 11. Drug Repurposing in Others
Figure 12. Global Drug Repurposing Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Drug Repurposing Market Size Market Share by Application in 2021
Figure 14. Global Drug Repurposing Revenue Market Share by Player in 2021
Figure 15. Global Drug Repurposing Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Drug Repurposing Market Size 2017-2022 ($ Millions)
Figure 17. APAC Drug Repurposing Market Size 2017-2022 ($ Millions)
Figure 18. Europe Drug Repurposing Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Drug Repurposing Market Size 2017-2022 ($ Millions)
Figure 20. Americas Drug Repurposing Value Market Share by Country in 2021
Figure 21. Americas Drug Repurposing Consumption Market Share by Type in 2021
Figure 22. Americas Drug Repurposing Market Size Market Share by Application in 2021
Figure 23. United States Drug Repurposing Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Drug Repurposing Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Drug Repurposing Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Drug Repurposing Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Drug Repurposing Market Size Market Share by Region in 2021
Figure 28. APAC Drug Repurposing Market Size Market Share by Application in 2021
Figure 29. China Drug Repurposing Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Drug Repurposing Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Drug Repurposing Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Drug Repurposing Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Drug Repurposing Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Drug Repurposing Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Drug Repurposing Market Size Market Share by Country in 2021
Figure 36. Europe Drug Repurposing Market Size Market Share by Type in 2021
Figure 37. Europe Drug Repurposing Market Size Market Share by Application in 2021
Figure 38. Germany Drug Repurposing Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Drug Repurposing Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Drug Repurposing Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Drug Repurposing Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Drug Repurposing Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Drug Repurposing Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Drug Repurposing Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Drug Repurposing Market Size Market Share by Application in 2021
Figure 46. Egypt Drug Repurposing Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Drug Repurposing Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Drug Repurposing Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Drug Repurposing Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Drug Repurposing Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 52. APAC Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 53. Europe Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 55. United States Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 56. Canada Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 59. China Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 60. Japan Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 61. Korea Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 63. India Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 64. Australia Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 65. Germany Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 66. France Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 67. UK Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 68. Italy Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 69. Russia Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 70. Spain Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 73. Israel Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Drug Repurposing Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
